22 December 2022

RNS REACH

RUA Life Sciences Plc

("RUA Life Sciences", the "Company" or the "Group")

Science Journal Publication

RUA Life Sciences, the holding company of a group of medical device businesses focused on the exploitation of the patented long-term implantable biostable polymer, Elast-EonTM, is pleased to announce that further to a presentation at EACTS in 2021 a detailed paper  has now been accepted for publication in the Journal of Surgical Research discussing the RUA large bore graft and its similar safety and performance to the control devices. The paper, titled "A Large-Diameter Vascular Graft Replacing Animal-Derived Sealants with an Elastomeric Polymer", can be read on Science Direct by following the link below:

www.sciencedirect.com/science/article/pii/S002248042200782X

A copy of the paper will also be available on the RUA Life Sciences website.

Bill Brown, Chairman of RUA Life Sciences quoted:

"I would like to thank the team at Leuven for the preparation of this paper. No surprises came out of the study and I am delighted that the RUA graft behaved well in surgical handling and overall outcome with the ElastEon sealant performing as expected with no indications of the adhesions."

For more information please contact:

RUA Life Sciences

Bill Brown, Chairman                                                               Tel: +44 (0)1294 317073  

Dr Caroline Stretton, Group MD                                            Tel: +44 (0)1294 317073